{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T14:26:54Z","timestamp":1785940014604,"version":"3.56.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-04941-z","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T03:43:57Z","timestamp":1753847037000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effectiveness of low-dose aspirin in reducing the risk of preeclampsia in women with chronic hypertension: an integrative literature review"],"prefix":"10.1186","volume":"25","author":[{"given":"Prisca","family":"Asiimwe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Nambozi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Brennaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Ngonzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gad","family":"Ruzaaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"issue":"1","key":"4941_CR1","first-page":"1","volume":"6","author":"N Al-Jameil","year":"2013","unstructured":"Al-Jameil N, et al. A brief overview of preeclampsia. J Clin Med Res. 2013;6(1):1.","journal-title":"J Clin Med Res"},{"issue":"30","key":"4941_CR2","doi-asserted-by":"publisher","first-page":"2303259","DOI":"10.1002\/advs.202303259","volume":"10","author":"SM Andrabi","year":"2023","unstructured":"Andrabi SM, et al. Nitric oxide: physiological functions, delivery, and biomedical applications. Adv Sci. 2023;10(30):2303259.","journal-title":"Adv Sci"},{"issue":"4","key":"4941_CR3","first-page":"58","volume":"13","author":"S Ashraf","year":"2024","unstructured":"Ashraf S, et al. To determine efficacy aspirin 150 mg vs 75 mg in prevention of preeclampsia and its associated complications. Pak J Med Dent. 2024;13(4):58\u201368.","journal-title":"Pak J Med Dent"},{"issue":"1\u20132","key":"4941_CR4","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3109\/07420528.2012.717455","volume":"30","author":"DE Ayala","year":"2013","unstructured":"Ayala DE, et al. Chronotherapy with low-dose aspirin for prevention of complications in pregnancy. Chronobiol Int. 2013;30(1\u20132):260\u201379.","journal-title":"Chronobiol Int"},{"issue":"S 01","key":"4941_CR5","doi-asserted-by":"publisher","first-page":"e2410","DOI":"10.1055\/s-0043-1771260","volume":"41","author":"M Ayyash","year":"2024","unstructured":"Ayyash M, et al. Efficacy and safety of aspirin 162 mg for preeclampsia prophylaxis in high-risk patients. Am J Perinatol. 2024;41(S 01):e2410\u20137.","journal-title":"Am J Perinatol"},{"issue":"3","key":"4941_CR6","doi-asserted-by":"publisher","first-page":"419. e411","DOI":"10.1016\/j.ajog.2020.03.004","volume":"223","author":"C Banala","year":"2020","unstructured":"Banala C, et al. Impact of the ACOG guideline regarding low-dose aspirin for prevention of superimposed preeclampsia in women with chronic hypertension. Am J Obstet Gynecol. 2020;223(3):419. e411-419. e416.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"4941_CR7","doi-asserted-by":"publisher","first-page":"e213808","DOI":"10.1001\/jamanetworkopen.2021.3808","volume":"4","author":"NA Bello","year":"2021","unstructured":"Bello NA, et al. Prevalence of hypertension among pregnant women when using the 2017 American College of Cardiology\/American Heart Association blood pressure guidelines and association with maternal and fetal outcomes. JAMA Netw Open. 2021;4(3):e213808\u2013e213808.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"4941_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","volume":"72","author":"MA Brown","year":"2018","unstructured":"Brown MA, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72(1):24\u201343.","journal-title":"Hypertension"},{"key":"4941_CR9","doi-asserted-by":"crossref","unstructured":"Burton GJ, et al. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019;366.","DOI":"10.1136\/bmj.l2381"},{"issue":"2","key":"4941_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3109\/10641955.2015.1137586","volume":"35","author":"E Camarena Pulido","year":"2016","unstructured":"Camarena Pulido E, et al. Efficacy of L-arginine for preventing preeclampsia in high-risk pregnancies: a double-blind, randomized, clinical trial. Hypertens Pregnancy. 2016;35(2):217\u201325.","journal-title":"Hypertens Pregnancy"},{"issue":"13","key":"4941_CR11","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1055\/s-0041-1727215","volume":"39","author":"C Carpentier","year":"2022","unstructured":"Carpentier C, et al. Aspirin responsiveness at a dose of 80 mg and its impact on birth weight when used in twin pregnancies: the GAP pilot randomized trial. Am J Perinatol. 2022;39(13):1396\u2013400.","journal-title":"Am J Perinatol"},{"issue":"2","key":"4941_CR12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1365-2753.2010.01382.x","volume":"16","author":"N Cartwright","year":"2010","unstructured":"Cartwright N, Munro E. The limitations of randomized controlled trials in predicting effectiveness. J Eval Clin Pract. 2010;16(2):260\u20136.","journal-title":"J Eval Clin Pract"},{"issue":"2","key":"4941_CR13","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ije\/dyl271","volume":"36","author":"JM Catov","year":"2007","unstructured":"Catov JM, et al. Risk of early or severe preeclampsia related to pre-existing conditions. Int J Epidemiol. 2007;36(2):412\u20139.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"4941_CR14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.ajog.2019.08.047","volume":"222","author":"P Chaemsaithong","year":"2020","unstructured":"Chaemsaithong P, et al. Does low-dose aspirin initiated before 11 weeks\u2019 gestation reduce the rate of preeclampsia? Am J Obstet Gynecol. 2020;222(5):437\u201350.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"4941_CR15","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1161\/HYPERTENSIONAHA.107.107565","volume":"51","author":"LC Chappell","year":"2008","unstructured":"Chappell LC, et al. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study. Hypertension. 2008;51(4):1002\u20139.","journal-title":"Hypertension"},{"issue":"4","key":"4941_CR16","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3390\/jcm13041022","volume":"13","author":"B Demuth","year":"2024","unstructured":"Demuth B, et al. Aspirin at 75 to 81 mg daily for the prevention of preterm pre-eclampsia: systematic review and meta-analysis. J Clin Med. 2024;13(4):1022.","journal-title":"J Clin Med"},{"issue":"4","key":"4941_CR17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/jhh.2013.100","volume":"28","author":"T Dorniak-Wall","year":"2014","unstructured":"Dorniak-Wall T, et al. The role of L-arginine in the prevention and treatment of pre-eclampsia: a systematic review of randomised trials. J Hum Hypertens. 2014;28(4):230\u20135.","journal-title":"J Hum Hypertens"},{"issue":"1","key":"4941_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0002-9378(99)70163-8","volume":"180","author":"A Dumont","year":"1999","unstructured":"Dumont A, et al. Effect of aspirin in pregnant women is dependent on increase in bleeding time. Am J Obstet Gynecol. 1999;180(1):135\u201340.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"4941_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/rfc2.97","volume":"3","author":"RH Elhalag","year":"2024","unstructured":"Elhalag RH, et al. Efficacy of aspirin for prevention of preeclampsia in twin pregnancy: a meta-analysis. Reprod Female Child Health. 2024;3(3): e97.","journal-title":"Reprod Female Child Health"},{"key":"4941_CR20","doi-asserted-by":"crossref","unstructured":"English FA, et al. Risk factors and effective management of preeclampsia. Integ Blood Pressure Control. 2015;7\u201312.","DOI":"10.2147\/IBPC.S50641"},{"key":"4941_CR21","first-page":"1","volume":"20","author":"C Finnegan","year":"2020","unstructured":"Finnegan C, Breathnach FM. The role of aspirin for preeclampsia prevention in women with diabetes. Curr DiabRep. 2020;20:1\u20136.","journal-title":"Curr DiabRep"},{"issue":"5","key":"4941_CR22","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.ajog.2023.06.031","volume":"229","author":"L Ghesquiere","year":"2023","unstructured":"Ghesquiere L, et al. Optimal dose of aspirin for the prevention of preterm preeclampsia. Am J Obstet Gynecol. 2023;229(5):574\u20135.","journal-title":"Am J Obstet Gynecol"},{"key":"4941_CR23","doi-asserted-by":"crossref","unstructured":"Guerrier G, et al. (2013). Factors associated with severe preeclampsia and eclampsia in Jahun, Nigeria. Int J Womens Health: 509\u2013513.","DOI":"10.2147\/IJWH.S47056"},{"issue":"1","key":"4941_CR24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1177\/1470320313475910","volume":"15","author":"S Gui","year":"2014","unstructured":"Gui S, et al. Arginine supplementation for improving maternal and neonatal outcomes in hypertensive disorder of pregnancy: a systematic review. J Renin Angiotensin Aldosterone Syst. 2014;15(1):88\u201396.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"1","key":"4941_CR25","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1161\/HYPERTENSIONAHA.118.11196","volume":"72","author":"A Hauspurg","year":"2018","unstructured":"Hauspurg A, et al. Aspirin effect on adverse pregnancy outcomes associated with stage 1 hypertension in a high-risk cohort. Hypertension. 2018;72(1):202\u20137.","journal-title":"Hypertension"},{"issue":"1","key":"4941_CR26","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0020-7292(94)90047-7","volume":"44","author":"J Hauth","year":"1994","unstructured":"Hauth J, et al. Low-dose aspirin therapy to prevent preeclampsia. Int J Gynecol Obstet. 1994;44(1):97\u201397.","journal-title":"Int J Gynecol Obstet"},{"key":"4941_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2165\/00115677-200715020-00006","volume":"15","author":"J Hawkshead","year":"2007","unstructured":"Hawkshead J, Krousel-Wood MA. Techniques for measuring medication adherence in hypertensive patients in outpatient settings: advantages and limitations. Dis Manag Health Out. 2007;15:109\u201318.","journal-title":"Dis Manag Health Out"},{"key":"4941_CR28","doi-asserted-by":"publisher","first-page":"205031212110324","DOI":"10.1177\/20503121211032480","volume":"9","author":"A Helou","year":"2021","unstructured":"Helou A, et al. \u2018I wish my body was stronger\u2019: A qualitative study of attitudes and behaviours regarding treatment of hypertensive disorders of pregnancy. SAGE Open Medicine. 2021;9:20503121211032480.","journal-title":"SAGE Open Medicine"},{"key":"4941_CR29","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1590\/S0034-71672012000600017","volume":"65","author":"AJ Henrique","year":"2012","unstructured":"Henrique AJ, et al. Resultado perinatal em mulheres portadoras de hipertens\u00e3o arterial cr\u00f4nica: revis\u00e3o integrativa da literatura. Rev Bras Enferm. 2012;65:1000\u201310.","journal-title":"Rev Bras Enferm"},{"issue":"4","key":"4941_CR30","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1161\/01.HYP.34.4.1016","volume":"34","author":"RC Hermida","year":"1999","unstructured":"Hermida RC, et al. Administration time\u2013dependent effects of aspirin in women at differing risk for preeclampsia. Hypertension. 1999;34(4):1016\u201323.","journal-title":"Hypertension"},{"key":"4941_CR31","doi-asserted-by":"crossref","unstructured":"Higgins JP, et al. Assessing risk of bias in a randomized trial. Cochrane handbook for systematic reviews of interventions. 2019;205\u201328.","DOI":"10.1002\/9781119536604.ch8"},{"issue":"5","key":"4941_CR32","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/jch.14821","volume":"26","author":"X Hu","year":"2024","unstructured":"Hu X, et al. The optimal dosage of aspirin for preventing preeclampsia in high-risk pregnant women: a network meta-analysis of 23 randomized controlled trials. J Clin Hypertens. 2024;26(5):455\u201364.","journal-title":"J Clin Hypertens"},{"issue":"5","key":"4941_CR33","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1111\/jch.14149","volume":"23","author":"J Huai","year":"2021","unstructured":"Huai J, et al. Preventive effect of aspirin on preeclampsia in high-risk pregnant women with stage 1 hypertension. J Clin Hypertens. 2021;23(5):1060\u20137.","journal-title":"J Clin Hypertens"},{"issue":"11","key":"4941_CR34","doi-asserted-by":"publisher","first-page":"14606","DOI":"10.3390\/ijms131114606","volume":"13","author":"L-T Huang","year":"2012","unstructured":"Huang L-T, et al. Roles of nitric oxide and asymmetric dimethylarginine in pregnancy and fetal programming. Int J Mol Sci. 2012;13(11):14606\u201322.","journal-title":"Int J Mol Sci"},{"key":"4941_CR35","first-page":"i4919","volume":"355","author":"P J\u00fcni","year":"2016","unstructured":"J\u00fcni P, et al. Risk of bias in non-randomized studies of interventions (ROBINS-I): detailed guidance. Br Med J. 2016;355:i4919.","journal-title":"Br Med J"},{"issue":"2","key":"4941_CR36","doi-asserted-by":"publisher","first-page":"S1182","DOI":"10.1016\/j.ajog.2020.11.029","volume":"226","author":"NA Kametas","year":"2022","unstructured":"Kametas NA, et al. Chronic hypertension and superimposed preeclampsia: screening and diagnosis. Am J Obstet Gynecol. 2022;226(2):S1182\u201395.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"4941_CR37","doi-asserted-by":"publisher","first-page":"6357","DOI":"10.15419\/bmrat.v11i4.882","volume":"11","author":"S Khansari","year":"2024","unstructured":"Khansari S, et al. The effect of L-arginine in the prevention of preeclampsia and intrauterine growth of the fetus in primigravid women: a randomized clinical trial. Biomed Res Ther. 2024;11(4):6357\u201362.","journal-title":"Biomed Res Ther"},{"issue":"9","key":"4941_CR38","doi-asserted-by":"publisher","first-page":"101845","DOI":"10.1016\/j.jogoh.2020.101845","volume":"49","author":"E Lecarpentier","year":"2020","unstructured":"Lecarpentier E, Haddad B. Aspirin for the prevention of placenta-mediated complications in pregnant women with chronic hypertension. J Gynecol Obstet Hum Reprod. 2020;49(9):101845.","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"5","key":"4941_CR39","doi-asserted-by":"publisher","first-page":"e62140","DOI":"10.1371\/journal.pone.0062140","volume":"8","author":"E Lecarpentier","year":"2013","unstructured":"Lecarpentier E, et al. Risk factors of superimposed preeclampsia in women with essential chronic hypertension treated before pregnancy. PLoS ONE. 2013;8(5):e62140.","journal-title":"PLoS ONE"},{"issue":"2","key":"4941_CR40","doi-asserted-by":"publisher","first-page":"S184","DOI":"10.1016\/j.ajog.2020.12.303","volume":"224","author":"ADA Lorreia","year":"2021","unstructured":"Lorreia ADA, et al. 281 Aspirin acceptance rate and perceived preeclampsia risk after the implementation of universal screening for preeclampsia. Am J Obstet Gynecol. 2021;224(2):S184.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"4941_CR41","doi-asserted-by":"publisher","first-page":"S1196","DOI":"10.1016\/j.ajog.2020.07.026","volume":"226","author":"LA Magee","year":"2022","unstructured":"Magee LA, et al. Toward personalized management of chronic hypertension in pregnancy. Am J Obstet Gynecol. 2022;226(2):S1196\u2013210.","journal-title":"Am J Obstet Gynecol"},{"key":"4941_CR42","doi-asserted-by":"crossref","unstructured":"Meher S, et al. Nitric oxide for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 1996;2010(2).","DOI":"10.1002\/14651858.CD006490"},{"issue":"1","key":"4941_CR43","doi-asserted-by":"publisher","first-page":"2217465","DOI":"10.1080\/14767058.2023.2217465","volume":"36","author":"D Menichini","year":"2023","unstructured":"Menichini D, et al. L-Arginine supplementation in pregnancy: a systematic review of maternal and fetal outcomes. J Matern Fetal Neonatal Med. 2023;36(1):2217465.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"10022","key":"4941_CR44","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0140-6736(15)00070-7","volume":"387","author":"BW Mol","year":"2016","unstructured":"Mol BW, et al. Pre-eclampsia. The Lancet. 2016;387(10022):999\u20131011.","journal-title":"The Lancet"},{"issue":"1","key":"4941_CR45","doi-asserted-by":"publisher","first-page":"2200879","DOI":"10.1080\/14767058.2023.2200879","volume":"36","author":"KA Muldoon","year":"2023","unstructured":"Muldoon KA, et al. Persisting risk factors for preeclampsia among high-risk pregnancies already using prophylactic aspirin: a multi-country retrospective investigation. J Matern Fetal Neonatal Med. 2023;36(1):2200879.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"4","key":"4941_CR46","first-page":"323","volume":"18","author":"F Naderipour","year":"2024","unstructured":"Naderipour F, et al. Efficacy of L-arginine for preventing preeclampsia and improving maternal and neonatal outcomes in high-risk pregnancies: a systematic review and meta-analysis. Int J Fertil Steril. 2024;18(4):323.","journal-title":"Int J Fertil Steril"},{"key":"4941_CR47","doi-asserted-by":"crossref","unstructured":"Ngene NC, Moodley J. (2024). Preventing maternal morbidity and mortality from preeclampsia and eclampsia particularly in low-and middle-income countries. Best Pract Res Clin Obstet Gynaecol 102473.","DOI":"10.1016\/j.bpobgyn.2024.102473"},{"issue":"2","key":"4941_CR48","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/ncpneph0035","volume":"1","author":"M Noris","year":"2005","unstructured":"Noris M, et al. Mechanisms of disease: pre-eclampsia. Nat Clin Pract Nephrol. 2005;1(2):98\u2013114.","journal-title":"Nat Clin Pract Nephrol"},{"key":"4941_CR49","unstructured":"Organization WH. WHO recommendations on antiplatelet agents for the prevention of pre-eclampsia, World Health Organization. 2021."},{"issue":"1","key":"4941_CR50","first-page":"R52","volume":"274","author":"A Oyekan","year":"1998","unstructured":"Oyekan A, McGiff J. Cytochrome P-450-derived eicosanoids participate in the renal functional effects of ET-1 in the anesthetized rat. Am J Physiol. 1998;274(1):R52\u201361.","journal-title":"Am J Physiol"},{"issue":"12","key":"4941_CR51","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1016\/j.ajpath.2016.08.010","volume":"186","author":"S Panagodage","year":"2016","unstructured":"Panagodage S, et al. Low-dose acetylsalicylic acid treatment modulates the production of cytokines and improves trophoblast function in an in vitro model of early-onset preeclampsia. Am J Pathol. 2016;186(12):3217\u201324.","journal-title":"Am J Pathol"},{"key":"4941_CR52","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/bs.apha.2023.01.002","volume":"97","author":"JV Pascale","year":"2023","unstructured":"Pascale JV, et al. 20-Hydroxyeicosatetraenoic acid (20-HETE): bioactions, receptors, vascular function, cardiometabolic disease and beyond. Adv Pharmacology, Elsevier. 2023;97:229\u201355.","journal-title":"Adv Pharmacology, Elsevier"},{"issue":"1","key":"4941_CR53","doi-asserted-by":"publisher","first-page":"5581570","DOI":"10.1155\/2021\/5581570","volume":"2021","author":"WN Phoswa","year":"2021","unstructured":"Phoswa WN, Khaliq OP. The role of oxidative stress in hypertensive disorders of pregnancy (preeclampsia, gestational hypertension) and metabolic disorder of pregnancy (gestational diabetes mellitus). Oxid Med Cell Longev. 2021;2021(1):5581570.","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"4941_CR54","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0143-4004(83)80043-5","volume":"4","author":"R Pijnenborg","year":"1983","unstructured":"Pijnenborg R, et al. Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta. 1983;4(4):397\u2013413.","journal-title":"Placenta"},{"issue":"5","key":"4941_CR55","doi-asserted-by":"publisher","first-page":"585. e581","DOI":"10.1016\/j.ajog.2017.07.038","volume":"217","author":"LC Poon","year":"2017","unstructured":"Poon LC, et al. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history. Am J Obstet Gynecol. 2017;217(5):585. e581.","journal-title":"Am J Obstet Gynecol."},{"issue":"7","key":"4941_CR56","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","volume":"124","author":"S Rana","year":"2019","unstructured":"Rana S, et al. Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res. 2019;124(7):1094\u2013112.","journal-title":"Circ Res"},{"issue":"6","key":"4941_CR57","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1111\/j.1447-0756.2010.01303.x","volume":"36","author":"N Rani","year":"2010","unstructured":"Rani N, et al. Role of oxidative stress markers and antioxidants in the placenta of preeclamptic patients. J Obstet Gynaecol Res. 2010;36(6):1189\u201394.","journal-title":"J Obstet Gynaecol Res"},{"issue":"4","key":"4941_CR58","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.ajog.2022.09.046","volume":"228","author":"EM Richards","year":"2023","unstructured":"Richards EM, et al. Low-dose aspirin for the prevention of superimposed preeclampsia in women with chronic hypertension: a systematic review and meta-analysis. Am J Obstet Gynecol. 2023;228(4):395\u2013408.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"4941_CR59","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ajog.2017.11.561","volume":"218","author":"S Roberge","year":"2018","unstructured":"Roberge S, et al. Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol. 2018;218(3):287-293. e281.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"4941_CR60","doi-asserted-by":"publisher","first-page":"S1108","DOI":"10.1016\/j.ajog.2020.08.045","volume":"226","author":"DL Rolnik","year":"2022","unstructured":"Rolnik DL, et al. Prevention of preeclampsia with aspirin. Am J Obstet Gynecol. 2022;226(2):S1108\u201319.","journal-title":"Am J Obstet Gynecol"},{"issue":"15","key":"4941_CR61","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.3390\/jcm13154427","volume":"13","author":"A Rottenstreich","year":"2024","unstructured":"Rottenstreich A. Controversies and clarifications regarding the role of aspirin in preeclampsia prevention: a focused review. J Clin Med. 2024;13(15):4427.","journal-title":"J Clin Med"},{"key":"4941_CR62","first-page":"S85","volume":"152","author":"Y Ruan","year":"2011","unstructured":"Ruan Y. Effect of administration of low-dose aspirin before bedtime on blood pressure in hypertensive patients: a meta-analysis. Int J Cardiol. 2011;152:S85\u20136.","journal-title":"Int J Cardiol"},{"issue":"5","key":"4941_CR63","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S0015-0282(99)00088-6","volume":"71","author":"M Rubinstein","year":"1999","unstructured":"Rubinstein M, et al. Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization: a prospective, randomized, double-blind placebo-controlled assay. Fertil Steril. 1999;71(5):825\u20139.","journal-title":"Fertil Steril"},{"issue":"2","key":"4941_CR64","doi-asserted-by":"publisher","first-page":"e0229622","DOI":"10.1371\/journal.pone.0229622","volume":"15","author":"R Shanmugalingam","year":"2020","unstructured":"Shanmugalingam R, et al. Factors that influence adherence to aspirin therapy in the prevention of preeclampsia amongst high-risk pregnant women: a mixed method analysis. PLoS ONE. 2020;15(2):e0229622.","journal-title":"PLoS ONE"},{"issue":"3","key":"4941_CR65","doi-asserted-by":"publisher","first-page":"512","DOI":"10.17267\/2238-2704rpf.v10i3.3039","volume":"10","author":"N Sharma","year":"2020","unstructured":"Sharma N, et al. Randomized clinical trial: gold standard of experimental designs-importance, advantages, disadvantages and prejudices. Revista Pesquisa em Fisioterapia. 2020;10(3):512\u20139.","journal-title":"Revista Pesquisa em Fisioterapia"},{"issue":"4","key":"4941_CR66","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/uog.23668","volume":"58","author":"L Shen","year":"2021","unstructured":"Shen L, et al. ASPRE trial: risk factors for development of preterm pre-eclampsia despite aspirin prophylaxis. Ultrasound Obstet Gynecol. 2021;58(4):546\u201352.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"4941_CR67","first-page":"551","volume":"74","author":"BM Sibai","year":"1989","unstructured":"Sibai BM, et al. Low-dose aspirin in pregnancy. Obstet Gynecol. 1989;74(4):551\u20137.","journal-title":"Obstet Gynecol"},{"key":"4941_CR68","doi-asserted-by":"crossref","unstructured":"Sinha N, et al. A randomized controlled study comparing the efficacy of 75mg versus 150mg aspirin for the prevention of preeclampsia in high-risk pregnant women. Cureus. 2023;15(5).","DOI":"10.7759\/cureus.39752"},{"issue":"5","key":"4941_CR69","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1161\/HYPERTENSIONAHA.109.134825","volume":"54","author":"JD Snoep","year":"2009","unstructured":"Snoep JD, et al. Time-dependent effects of low-dose aspirin on plasma renin activity, aldosterone, cortisol, and catecholamines. Hypertension. 2009;54(5):1136\u201342.","journal-title":"Hypertension"},{"key":"4941_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jri.2019.07.004","volume":"134","author":"AC Staff","year":"2019","unstructured":"Staff AC. The two-stage placental model of preeclampsia: An update. J Reprod Immunol. 2019;134:1\u201310.","journal-title":"J Reprod Immunol"},{"issue":"9","key":"4941_CR71","doi-asserted-by":"publisher","first-page":"e0239048","DOI":"10.1371\/journal.pone.0239048","volume":"15","author":"E Tesfa","year":"2020","unstructured":"Tesfa E, et al. Prevalence and determinants of hypertensive disorders of pregnancy in Ethiopia: a systematic review and meta-analysis. PLoS ONE. 2020;15(9):e0239048.","journal-title":"PLoS ONE"},{"issue":"1","key":"4941_CR72","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1080\/21642850.2021.1951273","volume":"9","author":"R Vinogradov","year":"2021","unstructured":"Vinogradov R, et al. Aspirin non-adherence in pregnant women at risk of preeclampsia (ANA): a qualitative study. Health Psychol Behav Med. 2021;9(1):681\u2013700.","journal-title":"Health Psychol Behav Med"},{"key":"4941_CR73","unstructured":"Wandabwa J, et al. Risk factors for severe pre-eclampsia and eclamsia in Mulago Hospital, Kampala, Uganda. East Afr Med J. 2010;87(10)."},{"key":"4941_CR74","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jclinepi.2015.06.005","volume":"69","author":"P Whiting","year":"2016","unstructured":"Whiting P, et al. ROBIS: a new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol. 2016;69:225\u201334.","journal-title":"J Clin Epidemiol"},{"key":"4941_CR75","doi-asserted-by":"crossref","unstructured":"Whittemore R. Rigour in integrative reviews. Rev Res Evid Nurs Pract Syst Rev. 2007;149\u201356.","DOI":"10.1002\/9780470692127.ch11"},{"issue":"6","key":"4941_CR76","doi-asserted-by":"publisher","first-page":"685. e681","DOI":"10.1016\/j.ajog.2017.08.110","volume":"217","author":"D Wright","year":"2017","unstructured":"Wright D, et al. Aspirin for Evidence-based preeclampsia prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia. Am J Obstet Gynecol. 2017;217(6):685. e681-685. e685.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"4941_CR77","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40001-023-01024-7","volume":"28","author":"Y Xiao","year":"2023","unstructured":"Xiao Y, et al. Aspirin 75 mg to prevent preeclampsia in high-risk pregnancies: a retrospective real-world study in China. Eur J Med Res. 2023;28(1):56.","journal-title":"Eur J Med Res"},{"issue":"7320","key":"4941_CR78","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature09505","volume":"468","author":"A Zhou","year":"2010","unstructured":"Zhou A, et al. A redox switch in angiotensinogen modulates angiotensin release. Nature. 2010;468(7320):108\u201311.","journal-title":"Nature"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04941-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-04941-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04941-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T09:47:20Z","timestamp":1757324840000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-04941-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4941"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-04941-z","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"assertion":[{"value":"9 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This paper did not require approval by the Ethics Research Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"554"}}